VQ Biomedical
Apex, US · Founded 2023 · Delaware corporation · 3 known investors
Find your way into VQ Biomedical
128 people in our graph share verified history with the VQ Biomedical team — schools, employers, funds. One of them is your warm intro.
Michael Brannanunlockedknows Stewart Farling · together at Duke University (overlapped)
×9knows the team · via Duke University
×2knows the team · via North Carolina State University
VQ Biomedical is developing a minimally-invasive intravascular catheter that delivers supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure, providing gas exchange independent of the lungs. It is positioned as an alternative to mechanical ventilation and VV-ECMO in critical care settings.
Founders & leadership
VQ Biomedical was founded in 2023 by Galen Robertson, Tobias Straube, Stewart Farling, Marc Deshusses, and Bruce Klitzman.
GR
Galen RobertsonCo-founder & CEO
TS
Tobias StraubeCo-founder & Chief Medical Officer
SF
Stewart FarlinginCo-founder & Lead EngineerStewart Farling holds a B.S. and M.S. from North Carolina State University and a Ph.D. from Duke University. He has approximately a decade of experimental research experience spanning bench work and field deployment, along with consulting work in soil and groundwater remediation, and is now co-founder and lead engineer at VQ Biomedical after completing doctoral research on intravascular oxygenation methods at Duke.
MD
Marc DeshussesCo-founder & Principal Scientist
BK
Bruce KlitzmanCo-founder & Scientific Advisor
Board
DE
JK
JOE KNIGHTBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2024
▶$1.6MraisedMar 2025 · 21 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMar 2025 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MARC DESHUSSESDirector
- TOBIAS STRAUBEExecutive Officer, Director
- Daniel E. EstayDirector
- GALEN ROBERTSONExecutive Officer, Director
- JOE KNIGHTDirector
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Cqmedical11 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Vektor Medical7 shared keywordsVektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.
Mobiamedical6 shared keywordsMobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
Companies competing with VQ Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does VQ Biomedical do?
- VQ Biomedical is developing a minimally-invasive intravascular catheter that delivers supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure, providing gas exchange independent of the lungs. It is positioned as an alternative to mechanical ventilation and VV-ECMO in critical care settings.
- Who founded VQ Biomedical?
- VQ Biomedical was founded by Galen Robertson, Tobias Straube, Stewart Farling, Marc Deshusses, Bruce Klitzman in 2023.
- Who are VQ Biomedical's investors?
- VQ Biomedical's investors include Duke Capital Partners, Wolfpack Investor Network, DCP.
- How much funding has VQ Biomedical raised?
- VQ Biomedical has disclosed $1.6M raised across 1 round.
- Where is VQ Biomedical headquartered?
- VQ Biomedical is headquartered in Apex, US.